Vitamin-Microbiota Crosstalk in Intestinal Inflammation and Carcinogenesis
- PMID: 36014889
- PMCID: PMC9414212
- DOI: 10.3390/nu14163383
Vitamin-Microbiota Crosstalk in Intestinal Inflammation and Carcinogenesis
Abstract
Inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC) are common diseases of the digestive system. Vitamin deficiencies and gut microbiota dysbiosis have a close relationship with the risk, development, and progression of IBD and CAC. There is a strong link between vitamins and the gut microbiome. Vitamins are extremely crucial for maintaining a healthy gut microbiota, promoting growth and development, metabolism, and innate immunity. Gut microbiota can not only influence the transport process of vitamins, but also produce vitamins to compensate for insufficient food intake. Emerging evidence suggests that oral vitamin supplementation can reduce inflammation levels and improve disease prognosis. In addition, improving the diet structure and consuming foods rich in vitamins not only help to improve the vitamin deficiency, but also help to reduce the risk of IBD. Fecal microbiota transplantation (FMT) and the application of vitamin-producing probiotics can better assist in the treatment of intestinal diseases. In this review, we discuss the interaction and therapeutic roles of vitamins and gut microbiota in IBD and CAC. We also summarize the methods of treating IBD and CAC by modulating vitamins. This may highlight strategies to target gut-microbiota-dependent alterations in vitamin metabolism in the context of IBD and CAC therapy.
Keywords: CAC; IBD; microbiome; therapy; vitamins.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.Semin Immunol. 2017 Aug;32:3-13. doi: 10.1016/j.smim.2017.04.003. Epub 2017 May 2. Semin Immunol. 2017. PMID: 28465070 Review.
-
Vitamin D in inflammatory bowel disease: more than just a supplement.Curr Opin Gastroenterol. 2018 Jul;34(4):217-225. doi: 10.1097/MOG.0000000000000449. Curr Opin Gastroenterol. 2018. PMID: 29762159 Review.
-
Loss of claudin-3 expression increases colitis risk by promoting Gut Dysbiosis.Gut Microbes. 2023 Dec;15(2):2282789. doi: 10.1080/19490976.2023.2282789. Epub 2023 Nov 27. Gut Microbes. 2023. PMID: 38010872 Free PMC article.
-
Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases.Int J Mol Sci. 2020 Dec 31;22(1):362. doi: 10.3390/ijms22010362. Int J Mol Sci. 2020. PMID: 33396382 Free PMC article. Review.
-
Gut microbiota, inflammatory bowel disease and colorectal cancer.World J Gastroenterol. 2022 Aug 14;28(30):4053-4060. doi: 10.3748/wjg.v28.i30.4053. World J Gastroenterol. 2022. PMID: 36157114 Free PMC article. Review.
Cited by
-
Tumorigenesis in Inflammatory Bowel Disease: Microbiota-Environment Interconnections.Cancers (Basel). 2023 Jun 15;15(12):3200. doi: 10.3390/cancers15123200. Cancers (Basel). 2023. PMID: 37370812 Free PMC article. Review.
-
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy.Front Nutr. 2023 Mar 2;10:1120168. doi: 10.3389/fnut.2023.1120168. eCollection 2023. Front Nutr. 2023. PMID: 36937361 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
